Low voltage activation of Ca V 1.3 L-type Ca 2؉ channels controls excitability in sensory cells and central neurons as well as sinoatrial node pacemaking. Ca V 1.3-mediated pacemaking determines neuronal vulnerability of dopaminergic striatal neurons affected in Parkinson disease. We have previously found that in Ca V 1.4 L-type Ca 2؉ channels, activation, voltage, and calcium-dependent inactivation are controlled by an intrinsic distal C-terminal modulator. Because alternative splicing in the Ca V 1.3 ␣1 subunit C terminus gives rise to a long (Ca V 1.3 42 ) and a short form (Ca V 1.3 42A ), we investigated if a C-terminal modulatory mechanism also controls Ca V 1.3 gating. The biophysical properties of both splice variants were compared after heterologous expression together with ␤3 and ␣2␦1 subunits in HEK-293 cells. Activation of calcium current through Ca V 1.3 42A channels was more pronounced at negative voltages, and inactivation was faster because of enhanced calcium-dependent inactivation. By investigating several Ca V 1.3 channel truncations, we restricted the modulator activity to the last 116 amino acids of the C terminus. The resulting Ca V 1.3 ⌬C116 channels showed gating properties similar to Ca V 1.3 42A that were reverted by co-expression of the corresponding C-terminal peptide C 116 . Fluorescence resonance energy transfer experiments confirmed an intramolecular protein interaction in the C terminus of Ca V 1.3 channels that also modulates calmodulin binding. These experiments revealed a novel mechanism of channel modulation enabling cells to tightly control Ca V 1.3 channel activity by alternative splicing. The absence of the C-terminal modulator in short splice forms facilitates Ca V 1.3 channel activation at lower voltages expected to favor Ca V 1.3 activity at threshold voltages as required for modulation of neuronal firing behavior and sinoatrial node pacemaking. FIGURE 6. Sequence alignment of LTCC C termini. A sequence alignment of neuronal human Ca V 1.3 (GenBank TM accession number NM_000720), Ca V 1.4 (Gen-Bank TM accession number AJ224874), and Ca V 1.2 (uniprot accession number Q13936) ␣1 subunits is shown. Sequence identity (dark gray), similarity (light gray) and gaps (Ϫ) are indicated. PCRD, proximal C-terminal regulatory domain; DCRD, distal C-terminal regulatory domain; CTM, dotted line. Position of Ca V 1.3 42A and truncation mutants Ca V 1.3 ⌬C473 , Ca V 1.3 ⌬C158, Ca V 1.3 ⌬C116 , and Ca V 1.3 ⌬C76 are indicated by black arrows. Position of exon 44 is given.
Ca 2ϩ influx through voltage-gated L-type Ca 2ϩ channels (LTCCs) 2 regulates numerous physiological functions, including muscle contraction, hormone release, neuronal firing and plasticity, sensory function, and cardiac pacemaking (1) . Four pore-forming ␣1 subunit isoforms (Ca V 1.1-Ca V 1.4) with different biophysical properties and expression profiles evolved to adjust LTCC Ca 2ϩ signals to cellular needs. Ca V 1.3 channels play a unique role for hearing (sensory signaling in cochlear inner hair cells (IHC)) and sinoatrial node (SAN, diastolic depolarization) function (2) . Ca V 1.3 channels appear ideally suited for these functions because the operating range of both IHCs and SAN cells is within a voltage range of about Ϫ60 and Ϫ40 mV where these channels can conduct inward current because of their negative activation range (Refs. 3-5 and for review see Ref. 6 ). In neurons, Ca V 1.3 channels also serve pacemaker function and shape neuronal firing (7, 8) . Ca 2ϩ influx through LTCCs is limited by a Ca 2ϩ -dependent feedback mechanism, the so-called calcium-dependent inactivation (CDI) (9) . CDI develops in response to local or global elevations of intracellular Ca 2ϩ sensed by channel-bound calmodulin (10, 11) . However, moderation of CDI is an important prerequisite in some cells, such as in IHCs (Ca V 1.3; [12] [13] [14] and in retinal photoreceptors (Ca V 1.4), where slow inactivation of I Ca is required for sensory signaling. In Ca V 1.4 channels, CDI is completely prevented by an intrinsic gating modulator located in the Ca V 1.4␣1 C terminus, and CDI is restored in C-terminal truncation mutants (15, 16) . This C-terminal gating modulator (CTM) not only prevents CDI but also shifts the activation voltage range to more positive potentials (15) . Gating modulation seems not to be limited to Ca V 1.4 because co-expression of C-terminal fragments of Ca V 1.2 channels also shifts their activation range to more positive voltages and inhibits pore opening (17) . Because C termini of Ca V 1.2 (and also Ca V 1.1) ␣1 subunits are proteolytically cleaved (18 -20) but remain noncovalently bound to proximal C-terminal domains, they may serve as autoinhibitory modules (17, 21) .
We hypothesized that Ca V 1.3 function may also be finetuned by a CTM domain similar to Ca V 1.1, Ca V 1.2, and Ca V 1.4. Unlike for other LTCC ␣1 subunits, alternative splicing generates Ca V 1.3 ␣1 subunits with long (usage of exon 42, Ca V 1.3 42 ) or short (usage of exon 42A, Ca V 1.3 42A ) C termini. A CTM would therefore confer different biophysical properties on Ca V 1.3 only if present as in certain (i.e. long) variants.
Here we provide unequivocal evidence that an intramolecular protein-protein interaction gives rise to substantial gating differences between Ca V 1.3 42 and Ca V 1.3 42A . Our finding that the long and the short splice variants are expressed in several mouse and human tissues suggests that both contribute to finetuning of physiological Ca V 1.3 channel function.
EXPERIMENTAL PROCEDURES

Cloning of cDNA Constructs
To generate splice variant Ca V 1.3 42A , the alternatively spliced exon 42A was introduced into Ca V 1.3 cDNA (Ca V 1.3 42 ϭ human Ca V 1.3 8A as in Ref. 4 , GenBank TM accession number EU363339) by co-ligating an EcoRI-BamHI-cut PCR product containing exon 42A from a rat brain ␣1 subunit (GenBank TM accession number M57682) with HindIII-EcoRI-cut Ca V 1.3 cDNA into HindIII-BamHI (4622-7100)-cut Ca V 1.3-pBS vector. The rat exon 42A amino acid sequence is identical to its human homologue. Human Ca V 1.3 containing exon 42A was subsequently cloned into vector pGFP Ϫ (wild type) short form of the Ca V 1.3 protein (4) . For analyzing the effects of exon 44, amino acid residues RTRYYETYI were introduced into an untagged construct containing the long Ca V 1.3 C terminus after position 1787 using standard PCR techniques. Ca V 1.3 ⌬C473 , Ca V 1.3 ⌬C158 , Ca V 1.3 ⌬C116 , and Ca V 1.3 ⌬C76 channels were constructed by introducing stop codons into untagged Ca V 1.3 42 at respective amino acid positions 1665, 1980, 2022, and 2062 followed by artificial restriction sites as follows: BamHI* for Ca V 1.3 ⌬C158 and Ca V 1.3 ⌬C76 , HpaI* for Ca V 1.3 ⌬C116 , and XhoI* for Ca V 1.3 ⌬C473 . Peptides GFP-C 158 , GFP-C 116 , and GFP-C 76 were constructed by ligating HindIII*-SalI*-flanked PCR products corresponding to amino acids 1980 -2137, 2022-2137, and 2062-2137 of Ca V 1.3 42 into the pGFP ϩ plasmid resulting in the corresponding GFP-tagged Ca V 1.3 C-terminal peptides (22) . For FRET analysis, all C-terminal Ca V 1.3 fragments were cloned either into the mammalian expression vector pEYFP-C1 for N-terminal EYFP labeling or vector pECFP-N1 for C-terminal enhanced CFP labeling (Clontech). N-terminally EYFP-labeled constructs 5Ј-HindIII* and 3Ј-SalI* restriction sites flanking nucleotide sequences corresponding to the following Ca V 1.3 amino acid positions were introduced and cloned into HindIII-SalI-cut vector pEYFP-C1 as follows: peptide EF-preIQ-IQ-postIQ, amino acids 1453-2137; EF-preIQ-IQ, amino acids 1453-1623; and EF-preIQ-IQ-PCRD, amino acids 1453-1664. To construct peptide EF-preIQ-IQ-PCRD RRQQ , arginines at positions 1640 and 1641 were mutated to glutamines by splicing by overlapping extension-PCR. For C 158 -CFP and C 116 -CFP, 5Ј-EcoRI* and 3Ј-BamHI* restriction sites were introduced to flanking nucle-otide sequences corresponding to Ca V 1.3 amino acid positions 1980 -2137 and 2022-2137 and cloned into EcoRI-BamHI-cut vector pECFP-N1. To generate enhanced CFP-C 116 DEQQ , aspartate and glutamate at positions 2073 and 2076 were mutated to glutamines by splicing by overlapping extension-PCR. Integrity of all constructs was confirmed by DNA sequencing (MWG Biotec, Martinsried, Germany). Construct Ca V 1.3 42 was subjected to full-length sequence analysis. Numbering of amino acids or nucleotide positions in all constructs refers to GenBank TM accession number EU363339. Asterisks indicate artificial restriction sites introduced by PCR.
Qualitative RT-PCR
Mouse tissue was prepared from C57B/6N wild-type mice. Total RNA was isolated from whole-brain and brain sub-regions using the RNAqueos-4PCR kit (Ambion, Foster City, CA). After DNase I treatment, RNA integrity was checked by the quality of the 28 S and 18 S rRNA bands on a denaturing agarose gel. Organ of Corti mRNA was prepared from P4 or P19 mice as described in Ref. 23 . Human total RNAs from brain, heart, pancreas, and retina were purchased from Clontech. One g of total RNA was used for first strand cDNA synthesis by reverse transcriptase (RevertAid TM H Minus First Strand cDNA synthesis kit, MBI; Fermentas, Hanover, Germany) and random hexamer primers. For PCR analysis, the forward (fwd) primer was located in exon 39 (GenBank TM accession number NM_028981 for mouse and EU363339 for human). To differentiate between Ca V 1.3 42 and Ca V 1.3 42A , specific reverse (rev) primers were designed, located either in exon 42 or 42A. The following primers were used for mouse: fwd primer, 5Ј-CAAC-CCTGTTTGCTTTGGTC-3Ј, and rev primer for exon 42, 5Ј-TATAGCCCGTCGGATTTCTG-3Ј (332-bp product); rev primer for exon 42A, 5Ј-CTTCCTTCCGGAGGAGTGC-3Ј (483-bp product). The following primers were used for human: fwd primer, 5Ј-AACCCTGTTTGCTTTGGTTC-3Ј, rev primer for exon 42, 5Ј-TATAGCACGCCGGATTTCTG-3Ј (331-bp product); rev primer for exon 42A, 5Ј-CCACCTTCC-GGAGGAGTG-3Ј (488-bp product). In mouse organ of Corti, splice variants were also detected with the following primer pairs: exon 42 fwd primer, 5Ј-CTGCTTGACCAAGTTGT-CCCTCCA-3Ј, rev primer, 5Ј-CTACAAGGTGGTAATGC-AAATCAT-3Ј; exon 42A, fwd primer, 5Ј-CGCGGATCCT-ACTTGACCAAGTTGTCCC-3Ј; rev primer, 5Ј-CGCAAGC-TTCTAGAGCATCCGTTCAAGC-3Ј. Mouse and human GAPDH was used as positive control as follows: for mouse (Gen-Bank TM accession number NM_008084), fwd primer, 5Ј-ACT-CCACTCACGGCAAATTC-3Ј, rev primer 5Ј-CACATTGGG-GGTAGGAACAC-3Ј (572-bp product); for human (GenBank TM accession number NM_002046), fwd primer, CAATGACCCCTTCATTGACC, rev primer, 5Ј-GAGGCAG-GGATGATGTTCTG-3Ј (531-bp product). 500 ng (2.7 g for organ of Corti) of reverse-transcribed cDNA was used as template for each PCR. Samples without template were used as contamination control. The following PCR program was used: 94°C for 3 min, 40 cycles of 94°C for 45 s, 55°C for 45 s, and 68°C for 1 min, followed by an elongation step of 68°C for 10 min. PCRs were performed using BioTherm TM TaqDNA polymerase (GeneCraft, Lüdinghausen, Germany) in the presence of 1.5 mM MgCl 2 . The resulting PCR products were subcloned into pGEM-T Easy vectors (Promega, Mannheim, Germany) and sequenced.
Quantitative RT-PCR
RNA Isolation and cDNA Preparation-Tissue from three adult male c57BL/6N mice (3-6 months) was used for wholebrain and brain sub-region cDNA preparations. Total RNA and cDNA were prepared as described (24) .
Quantitative RT-PCR-The relative abundance of different Ca V 1.3 mRNAs was assessed by TaqMan quantitative PCR (50 cycles) using a standard curve method as described (24) . Taq-Man gene expression assays, designed to span exon-exon boundaries, were purchased from Applied Biosystems (Foster City, CA). Assessment of mouse GAPDH transcripts was included as efficiency reference. Assay identification numbers are as follows: exon 42, Mm0551393_m1 (efficiency (E) ϭ 103.6%); exon 42A (E ϭ 98.7%), custom-designed (fwd primer, 5Ј-GGAAGTACCCTGCGAAGAACAC-3Ј; probe, 5Ј-TTGC-CCTACAGATGCTTG-3Ј; rev primer, 5Ј-CTCAGGCAGAG-AACTCTAAAGCAT-3Ј); GAPDH, Mm99999915_g1. To amplify specific cDNA templates from the analyzed tissues for the standard curves of each assay, primer pairs were as follows: exon 42 fwd primer, 5Ј-CAACCCTGTTTGCTTTGGTC-3Ј, rev primer, 5Ј-TGATTGACATGGTTTCCAAGC-3Ј; exon 42A fwd primer, 5Ј-CAACCCTGTTTGCTTTGGTC-3Ј, rev primer, 5Ј-CTTCCTTCCGGAGGAGTGC-3Ј. Analysis was carried out in triplicate.
Cell Culture and Transient Expression-HEK-293 (tsA-201) cells were cultured and transfected as described previously (4) . Untagged Ca V 1.3␣1 constructs were expressed together with ␤3 (or ␤2a) and ␣ 2 ␦ 1 subunits (4). In co-expression studies, GFP-labeled C-terminal Ca V 1.3 fragments were used to ensure the presence of the corresponding C-terminal peptide in the cell recorded. Immunoblotting was performed as described previously (25) using a generic anti-␣1 sequence-directed antibody as described previously (4) . All constructs were expressed with the expected molecular mass.
Electrophysiological Recordings-Whole-cell patch clamp recordings in transiently transfected HEK-293 (tsA-201) cells were performed 2-3 days after transfection using either 15 mM Ba 2ϩ or Ca 2ϩ as charge carrier as described in Ref. 4 . Recording solutions were composed as follows (in mM): intracellular solution, 135 CsCl, 10 Cs-EGTA, 1 MgCl 2 adjusted to pH 7.4 with CsOH (311 mosM); bath solution, 15 BaCl 2 , 10 HEPES, 150 choline-Cl, and 1 MgCl 2 , adjusted to pH 7.4 with CsOH (358 mosM). Transfected cells were visualized by co-expression of GFP or GFP-or YFP-labeled constructs co-expressed with the channel complex as indicated. Current-voltage (I-V) relationships were obtained by holding cells at a potential of Ϫ90 mV before applying 50-ms or 300-ms pulses to various test potentials. I-V curves were fitted to the equation
where V rev is the extrapolated reversal potential; V is the test potential; I is the peak current amplitude; G max is the maximum slope conductance; V 0.5,act is the half-maximal activation voltage; and k is the slope factor. Percentage of inactivation was determined at specified time points during depolarizing pulses from a holding potential of Ϫ90 mV to the peak current potential (V max ) of the I-V relation of the individual cell. The voltage dependence of inactivation was assessed by application of a 20-ms test pulse to V max before and after holding cells at various conditioning test potentials for 5 s. Steady-state inactivation curves were analyzed using the Boltzmann relationship I ϭ I SS ϩ (1 Ϫ I SS )/(1 ϩ exp(V Ϫ V 0.5,inact /k inact )), where I is the peak current amplitude; I SS is the noninactivating fraction; V is the membrane potential; V 0.5,inact is the half-inactivation potential; and k inact is the slope factor. To investigate Ca V 1.3 42 and Ca V 1.3 42A gating properties, headto-head analysis was performed time-independently by two investigators. Experiments showing currents bigger than 3 nA were prospectively excluded from analysis of activation and inactivation parameters to guarantee high quality voltage clamp. CDI was quantified as the current remaining at the end of 250-ms depolarizations to different test potentials, expressed as fraction of peak current amplitude (r 250 ). Parameter f was defined as the difference between r 250 values of I Ba and I Ca at ϩ10 mV. CDI experiments were performed on different cells, but effects were the same when the charge carrier was switched from Ba 2ϩ to Ca 2ϩ on the same cell in representative experiments. All voltages were corrected for the liquid junction potential.
Confocal FRET Microscopy
Confocal FRET microscopy was performed as described previously (15) . As negative controls, peptide YFP-EF-PreIQ-IQ-PCRD was co-expressed with CFP alone (CFP control), and probes CFP-C 158 or CFP-C 116 with YFP alone (YFP controls 1 and 2). Image analysis was accomplished using a self-made program integrated in MatLab 7 based on the FRET analysis algorithm proposed (26) . Interaction between fragments was considered when a significant difference to the CFP as well as the corresponding YFP control was observed. The local ratio between CFP and YFP might vary because of different local expression levels of the different protein constructs, which could affect calculation of FRET values. Therefore, analysis was limited to pixels with a CFP:YFP molar ratio between 1:10 and 10:1.
Statistical Analysis
Data were analyzed using Clampfit 9.0 (Molecular Devices, Union City, CA) and Microcal Origin 5.0 (Northampton, MA). Significant difference between the two splice variants was assessed a priori by pairwise comparison before other truncation constructs to characterize the modulatory mechanism were made. Student's t test or Mann-Whitney test were used for comparison between two groups for parametric and nonparametric data, respectively. Statistical significance was determined using one-way ANOVA followed by Bonferroni posttest, except if stated otherwise. Statistical significance was set at p Ͻ 0.05. All data are presented as mean Ϯ S.E. for the indicated number of experiments.
urally occurring Ca V 1.3 ␣1 subunit splice variants, Ca V 1.3 42 and Ca V 1.3 42A (also termed Ca V 1.3a and Ca V 1.3b, respectively (5, 27, 28) ), which differ with respect to the length of their C termini, as illustrated in Fig. 1a . Similar to the Ca V 1.4 trun-cation mutant K1591X (15), Ca V 1.3 42A terminates shortly after the IQ motif and lacks most of a homologous region (termed PCRD) previously found to participate in the binding of distal C-terminal sequences in Ca V 1.2 (17) . Wild-type long and short Ca V 1.3 ␣1 subunits were expressed in HEK-293 cells together with ␤3 (or ␤2a) and ␣2␦ 1. ␤3 subunits were selected because we have previously shown that they form a large fraction of dihydropyridine-sensitive LTCCs in the brain (29) . Both ␣1 subunits migrated with the expected molecular mass in Western blots of HEK-293 cell preparations ( Fig. 1b) .
We systematically investigated the biophysical properties of both I Ca and I Ba for Ca V 1.3 42 and Ca V 1.3 42A as illustrated in Figs. 2 and 3 and Tables 1-3. The voltage dependence of I Ca activation of Ca V 1.3 42A was significantly shifted to hyperpolarizing potentials by about 10 mV (Ca V 1.3 42 Table 1 ). This negative shift was because of the significant decrease in k act (Ca V 1.3 42 :
Ϫ6.9 Ϯ 0.2, n ϭ 15; p Ͻ 0.001; see Table 1 ) without change in the activation threshold ( Fig. 2a ). Such changes were also observed for I Ba ( Table 2 ). The negative activation range persisted when subgroups of cells with different current amplitudes (0.1-0.6 versus 0.7-2.3 nA) were compared ( Fig. 2c ). It was not restricted to ␤3 subunit-containing channel complexes because it was also seen when the Ca V 1.3 splice variants were co-expressed with ␤2a subunits (V 0.5,act , I Ca , Ca V 1.3 42 ( Fig. 1b, n ϭ 4) . Depolarization to the reversal potential (V rev ) revealed a small ON-gating current which was always detectable for Ca V 1.3 42 channels but was absent (or much reduced) in Ca V 1.3 42A currents (Fig. 2d ). This further suggests that the larger current amplitude of Ca V 1.3 42A channels was not because of an increased expression density of channels at the plasma membrane in line with the immunoblot analysis.
The short C terminus also resulted in a slight decrease of V rev (with a larger and statistically significantly difference for I Ba ; see Tables 1 and 2 ). The half-maximal voltage of steady-state inactivation (V 0.5,inact ) induced by 10-s conditioning pulses ( Fig. 2e ) for the physiological charge carrier was also significantly shifted toward more negative voltages in Ca V 1.3 42A channels (Ca V 1.3 42 Ϫ4.9 Ϯ 0.5 mV, n ϭ 4, p ϭ 0.03, Student's t test) was also observed. Theses changes in the voltage dependence of steadystate activation and inactivation resulted in a shift of the window current toward more hyperpolarizing voltages for Ca V 1.3 42A (Fig. 2e ). Our data demonstrate that the structural divergence within the C termini of these Ca V 1.3 splice variants causes pronounced changes in channel gating suggesting the existence of a CTM in Ca V 1.3 LTCCs that controls their activity at negative voltages.
Ca V 1.3 C Terminus Modulates Ca 2ϩ -dependent Inactivation
Properties-As already obvious from the representative current traces in Fig. 2b , Ca V 1.3 42A channels inactivate faster during depolarization to different test potentials than Ca V 1.3 42 channels. This is also evident from a detailed comparison of I Ca inactivation during 10-s pulses to the maximum of the I-V curve (V max ) ( Fig. 3 , a and b; Table 3 ). The difference was most pronounced during the first 30 ms (% inactivation: Ca V 1.3 42 , 27.5 Ϯ 1.9, n ϭ 16; Ca V 1.3 42A , 73.6 Ϯ 1.9, n ϭ 19, p Ͻ 0.001; Fig.  3 , a, inset, and b, and Table 3 ). Inactivation included an initial fast component followed by a slow component in both isoforms. Inactivation was not complete even during 10 s (Ca V 1.3 42 , 96.9 Ϯ 0.7%, n ϭ 14; Ca V 1.3 42A , 98.1 Ϯ 0.3%, n ϭ 17; one sample t test, compared with 100%: p ϭ 0.0006 for Ca V 1.3 42 and p ϭ 0.0001 for Ca V 1.3 42A ) suggesting that some Ca 2ϩ influx through Ca V 1.3 channels may persist even during extended periods of strong depolarization. Faster I Ca inactivation of Ca V 1.3 42A was also seen at physiologically more relevant potentials, as indicated by a significant decrease in integrated I Ca during 300-ms test pulses (Fig. 3c ). Note that voltage dependence of activation and inactivation is shifted by ϳ15 mV to more positive voltages under our recording conditions (5) . Therefore, Ϫ20 mV corresponds to about Ϫ35 mV at physiological Ca 2ϩ concentrations. The faster inactivation of Ca V 1.3 42A could be due to faster voltage-dependent inactivation, faster CDI, or both. To address this question, we also quantified Ca V 1.3-mediated I Ba of both splice variants. Interestingly, mean I Ba inactivation was even slower for Ca V 1.3 42A channels ( Fig. 3d and Table 3 ). This difference was because of a pronounced slowing of inactivation in 50% of the cells (% inactivation of Ca V 1.3 42A during 250 ms, 8.6 Ϯ 1.2%, n ϭ 7, in this subset). We have previously observed a similar slowing of inactivation of I Ba in truncated Ca V 1.4 channels (15) .
From these data we conclude that the faster inactivation of I Ca observed for Ca V 1.3 42A must be due to more pronounced CDI. As a quantitative measure of CDI, we analyzed the fraction of I Ca through Ca V 1.3 channels remaining after a 250-ms depolarization (r 250 ) in a wide voltage range (Fig. 3e) . A typical U-shaped dependence on test voltage was observed for both splice variants, but it was more pronounced for Ca V 1.3 42A channels (f ϭ 0.60 Ϯ 0.07 versus 0.25 Ϯ 0.11 at 10 mV for Ca V 1.3 42 channels). In agreement with a previous report (13) , Ca V 1.3 CDI was CaM-mediated. I Ca inactivation of Ca V 1.3 42A channels was dramatically slowed by co-expression of YFP-labeled dominant-negative CaM (CaM 1234 ) (r 250 at V max : Ca V 1.3 42A ϩ CaM 1234 , 0.76 Ϯ 0.061%, n ϭ 5, p Ͻ 0.0001, Student's t test versus Ca V 1.3 42A ) thus approaching r 250 values for I Ba (for comparison see Fig. 3e ). CaM 1234 did not affect the hyperpolarizing shift of the I Ca activation (V 0.5,act : Ca V 1.3 42A ϩ CaM 1234 : Ϫ16.3 Ϯ 0.5 mV, n ϭ 8) suggesting that the shift in activation voltage occurs independent of CaM as also shown previously for Ca V 1.4 (15) . Taken together, these data provide unequivocal evidence that the CTM in Ca V 1.3 channels not only modulates its activity range but also moderates CDI. (Tables 1 and 2) . For I Ca , k act significantly decreased (Ca V 1.3 ⌬C158 : Ϫ7.4 Ϯ 0.2, n ϭ 9; p Ͻ 0.001; Table 1 ), and V 0.5,act (Ca V 1.3 ⌬C158 : Ϫ14.3 Ϯ 0.4 mV, n ϭ 9, p Ͻ 0.001; Table  1 ) shifted to more hyperpolarized voltages. Like in Ca V 1.3 42A , I Ca inactivation was faster, and CDI was more pronounced, and I Ba was slowed (for all data and statistics see Tables 1-3) .
To prove the modulatory role of the last 158 amino acid residues, we tested the capability of this C-terminal fragment to restore the gating changes induced by the truncation. Therefore, GFP-fused peptide (GFP-C 158 ) was expressed together with the respective truncated channel. GFP-C 158 reverted the gating changes observed in Ca V 1.3 ⌬C158 channels to values sim- Table 3 ). Number of experiments is given in parentheses. Error bars reflect S.E.
TABLE 3 I Ca and I Ba inactivation and CDI properties of Ca V 1.3 42 and Ca V 1.3 42A channels in comparison with different C-terminally truncated Ca V 1.3 channel constructs
Number of experiments is indicated in parentheses. 42 ; the hyperpolarizing shift of the I Ca activation curve was reversed (V 0.5, act : Ca V 1.3 ⌬C158 ϩ GFP-C 158 , Ϫ0.8 Ϯ 1.4 mV n ϭ 8, p ϭ 0.3 versus Ca V 1.3 42 ; see Table 1 ); I Ca inactivation was slowed (during 30 ms: Ca V 1.3 ⌬C158 ϩ GFP-C 158 ; 23.5 Ϯ 1.9%, n ϭ 8, p ϭ 0.2 versus Ca V 1.3 42 ; see Table 3 ), and CDI was less pronounced as indicated by the decrease of the f value (at 10 mV, Ca V 1.3 ⌬C158 ϩ GFP-C 158 , 0.2 Ϯ 0.08, n ϭ 6 -8; see Table 3 ). Peptide-induced reversal of activation and inactivation parameters was also observed in I Ba (Table 2) .
Construct
To further restrict the protein domain important for CTM activity, we introduced additional truncations in the distal C terminus (Figs. 4 -6) . Deletion of the last 76 (Ca V 1.3 ⌬C76 ) amino acids induced the same gating effects as described for Ca V 1.3 ⌬C158 . However, Ca V 1.3 ⌬C76 channel activity was not reverted to Ca V 1.3 42 -like behavior by co-expression of peptide GFP-C 76 (for data and statistics see Tables 1-3 ). This could not be explained by a lack of GFP-C 76 expression because fulllength expression of this peptide was confirmed in Western blot experiments where the peptide expressed at comparable levels to GFP-C 158 (n ϭ 3, not illustrated). Our data therefore suggest that the last 76 amino acids are required for the formation of CTM activity but cannot functionally recombine with its truncated counterpart to form a modulatory structure. Sequence alignment with other LTCCs (Fig. 6 ) revealed that truncation ⌬C76 cuts in half the most distal highly conserved domain. This may prevent recombination to a functional domain upon co-expression. Hence, we generated Ca V 1.3 ⌬C116 in which the conserved region was fully removed and subsequently co-expressed as a single peptide. As shown in Fig. 4 and Tables 1-3, Ca V 1.3 ⌬C116 again exhibited functional I Ca and I Ba properties similar to Ca V 1.3 42A . However, unlike in Ca V 1.3 ⌬C76 , the gating properties were reversed to those of Ca V 1.3 42 after co-expression of the GFP-C 116 peptide ( Fig. 4 and Tables  1-3 ). Co-expression of the corresponding distal peptides not only reversed activation parameters and CDI but also significantly decreased mean I Ca density by 53-63% (p Ͻ 0.05, n ϭ 7-11). A similar trend was also seen for I Ba (41Ϫ67%, n ϭ 7-11). These data implicate that Ca V 1.3 ␣1 subunits contain critical structural elements required for CTM function within the last 76 amino acids and that the last 116 residues perform CTM activity when co-expressed in HEK-293 cells.
Intramolecular Protein-Protein Interaction Regulates Ca V 1.3 Channel Gating-We (15) and others (16) showed that in Ca V 1.4 ␣1 subunits the distal CTM interacts with a more proximal domain containing the EF-hand, pre-IQ-, and IQ-motif. If such a mechanism also holds true for Ca V 1.3 channels, CTM-containing peptides should also modulate Ca V 1.3 42A (containing EF-PreIQ-IQ). Interestingly, co-expression of GFP-C 158 neither reversed the Ca V 1.3 42A -induced hyperpolarizing shift of the activation range of I Ca (Ca V 1.3 42A ϩ GFP-C 158 : V 0.5,act ϭ Ϫ12.6 Ϯ 1.5 mV, n ϭ 7; p Ͻ 0.001; see Fig. 5a and Table 1 ) and I Ba (Table 2 ) nor the voltage-dependent inactivation and CDI (Fig. 5, b and c; Table 3 ). This prompted us to extend the Ca V 1.3 ␣1 subunit C terminus to residue 1664 thereby including a highly conserved domain downstream of the IQ-motif that is missing in Ca V 1.3 42A and also contains the so-called PCRD domain previously identified as binding partner for C-terminal peptides in Ca V 1.2 channels ( Fig. 6) (17) . As expected, the resulting Ca V 1.3 ⌬C473 channels showed Ca V 1.3 42A -like gating (Tables 1-3) but, in contrast to Ca V 1.3 42A , co-expression of GFP-C 116 restored CDI (Fig. 5, h and i; Table 3 ) and the activation and inactivation parameters for I Ca (Fig. 5, d-f and h and i; and Tables 1 and 3 ) and I Ba (Tables 2 and 3 ) close to Ca V 1.3 42 values. These data provide functional evidence for an important role of proximal residues 1626 -1664 and the distal 116 amino acids for CTM function.
To provide further evidence for this mechanism, we measured FRET between different YFP-labeled C-terminal fragments and CFP-labeled C 158 (CFP-C 158 ) as well as CFP-labeled C 116 (CFP-C 116 ) (Fig. 7) . The construct corresponding to the C-terminal fragment of Ca V 1.3 42A (YFP-EF-PreIQ-IQ) did not show significant FRET with the CFP-C 158 probe (legend to Fig.  7) . By extending the Ca V 1.3 YFP-EF-preIQ-IQ bait to residue 1664 yielding YFP-EF-preIQ-IQ-PCRD, a strong and significant FRET signal was measured with CFP-C 158 as well CFP-C 116 (Fig. 7) , which is in excellent agreement with our electrophysiological data. Accordingly, no FRET was observed when CFP-C 76 peptide was used as a probe (not shown). For Ca V 1.2 channels, interaction between a pair of arginine residues in the PCRD and a set of negatively charged residues in the distal C-terminal region (DCRD) was predicted ( Fig. 6) (17) . As shown in Fig. 7 , mutating the two conserved arginines in the Ca V 1.3 PCRD to glutamine (EF-preIQ-IQ-PCRD RRQQ containing R1640Q and R1641Q) still supported a significant FRET signal when co-expressed with CFP-C 116 . Using probe CFP-C 116 DEQQ , where the two negative charges in DCRD conserved in Ca V 1.3 were neutralized (D2073Q and E2076Q), significant FRET was eliminated for both EF-preIQ-IQ-PCRD and EF-preIQ-IQ-PCRD RRQQ . Therefore, neutralization of the two positive charges of the PCRD arginines is not sufficient to prevent the binding interaction suggesting that other binding determinants exist in the conserved domain between residues 1626 and 1664. Our data indicate an essential role of the two negative charges in the Ca V 1.3 42 DCRD region, similar to Ca V 1.2.
To address the question if the moderation of CDI by the CTM involves modulation of CaM interaction with its C-terminal interaction domains, we measured if the presence of the CTM can affect the constitutive binding of CaM at resting intracellular Ca 2ϩ concentrations. We measured FRET between CFP-labeled calmodulin (CFP-CaM) and the fragments YFP-EF-preIQ-IQ (mimicking the short Ca V 1.3 42A ), YFP-EF-preIQ-IQ-PCRD, and a peptide corresponding to the complete Ca V 1.3 C terminus (YFP-Ca V 1.3-C terminus), including the CTM (corresponding to the long Ca V 1.3 42 ). Whereas significant N FRET (p Ͻ 0.001 versus YFP-Ca V 1.3-C terminus; one-way ANOVA, Bonferroni post-test) was measured for YFP-EF-preIQ-IQ (0.185 Ϯ 0.009, n ϭ 12) and YFP-EF-preIQ-IQ-PCRD (0.235 Ϯ 0.007, n ϭ 3), no significant N FRET was obtained for YFP-Ca V 1.3-C terminus (0.039 Ϯ 0.017, n ϭ 6, p ϭ 0.07. one-sample t test, compared with 0). This is in excellent agreement with our previous findings in Ca V 1.4 channels (15) indicating that the Ca V 1.3 CTM interferes with CaM coordination to the C terminus in intact cells. This also provides a plausible mechanism for explaining the moderation of CDI.
We also investigated whether the function of the CTM was prevented by alternative splicing of exon 44 in the post-IQ region of the C terminus ( Fig. 6 ). Introduction of 9 amino acid corresponding to exon 44 into a full-length Ca V 1.3 construct (Ca V 1.3 42ϩ44 ) exhibited activation parameters similar to Ca V 1.3 42 (I Ba : V 0.5, act ϭ Ϫ14.8 Ϯ 1.2 mV, k act ϭ Ϫ9.3 Ϯ 0.3 mV, n ϭ 14; I Ca , V 0.5, act ϭ Ϫ3.7 Ϯ 1.02 mV, k act ϭ Ϫ10.6 Ϯ 0.3 mV, n ϭ 8) suggesting that CTM function was not prevented by alternative splicing of this exon.
Ca V 1.3 42 and Ca V 1.3 42A Are Both Expressed in Mouse and Human Tissues-We employed PCR to determine whether both long (CTM-containing) and short (CTM-deficient) splice variants are expressed in mouse and human tissue. RT-PCR experiments identified both exon 42 and 42A mRNA in different mouse brain regions and the organ of Corti (Fig. 8a) as well as in human brain, heart, retina, and pancreas (Fig. 8b) . Using quantitative real time PCR, we determined the relative abundance of these transcripts in mouse whole-brain as well as several brain sub-regions (Fig. 8c ). Because exons 42 and 42A are used in a mutually exclusive manner, we calculated the relative amount of exon 42A as percentage of the sum of exon 42 and 42A containing mRNA molecules in samples from two to three independent RNA preparations. Although exon 42 was the predominant form in whole-brain and all sub-regions investigated, significant expression of exon 42A was also found. In wholebrain preparations, exon 42A was 11.0 Ϯ 0.6% (n ϭ 8) of the two mRNAs. Variable expression was found in brain sub-regions with the highest expression in cerebellum (17.1 Ϯ 2.5%, n ϭ 4) and the nucleus accumbens (13.3 Ϯ 1.5%, n ϭ 3) and the lowest in olfactory bulb (2.1 Ϯ 0.2%, n ϭ 3). These data suggest that the short Ca V 1.3 splice variant can contribute significantly to overall Ca V 1.3 activity. Notably, our experiments do not rule out the possibility of other short isoforms with gating properties similar to Ca V 1.3 42A . Therefore the contribution of short forms to overall Ca V 1.3 expression is likely to be underestimated by our experiments.
DISCUSSION
Here we present functional evidence for a C-terminal automodulatory domain that controls voltage-and Ca 2ϩ -dependent gating properties of Ca V 1.3 LTCCs. Such modulation has not been described for Ca V 1.3 channels before. The absence of the CTM in the short splice variant Ca V 1.3 42A provides functional diversity to Ca V 1.3 channels. Ca V 1.3 42A mRNA is expressed together with Ca V 1.3 42 in different mouse and human tissues suggesting that this functional diversity is of physiological relevance to adapt Ca V 1.3 channel activity for specific physiological needs. Activation at negative voltages is one hallmark of Ca V 1.3 channels (for review see Ref. 6 ) crucial for adequate neurotransmitter release in IHCs and pacemaker function in the SAN, atrioventricular conduction (30, 31) , and neuronal excitability (7, 32) . In the absence of the CTM, V 0.5,act is shifted about 10 mV to more negative voltages by decreasing the slope factor of the activation curve but without measurable effects on the activation threshold. This effect was not correlated with current densities, was independent from cell passage number, and was reproducibly observed for splice variant Ca V 1.3 42A as well as for several truncations mutants. Moreover, it could not be attributed to artificial manipulations of the Ca V 1.3␣1 subunits because it was observed in wild-type channel constructs not modified by fusion to GFP or introduction of other tags. In addition, co-expression of peptides containing the CTM with truncation mutants Ca V 1.3 ⌬C116 , Ca V 1.3 ⌬C158 , and Ca V 1.3 ⌬C473 reversed this shift. Cells may therefore adjust the activity of Ca V 1.3-mediated signaling by varying the relative abundance of CTM-containing splice variants.
The functional properties of Ca V 1.3 42 and Ca V 1.3 42A channels have been studied in previous reports. In two studies functional differences were observed between these splice variants, termed Ca V 1.3a and Ca V 1.3b therein, respectively. Calin-Jageman et al. (39) found that VDF of rat Ca V 1.3 channels expressed in HEK-293T cells was significantly more pronounced for Ca V 1.3 42A than for Ca V 1.3 42 suggesting an autoinhibitory effect of the C-terminal tail on VDF. Comparisons of I-V relationship and I Ca were not reported in this study. Zhang et al. (37) expressed hemagglutinin-tagged splice variants in Xenopus laevis oocytes and found that I Ba of the Ca V 1.3 42A construct was not only larger in amplitude but also its I-V relationship was shifted toward more negative voltages, similar to our findings. I Ca was not reported. Although a more detailed comparison of the biophysical properties of Ca V 1.3 42 and Ca V 1.3 42A was not the purpose of these studies, they support a modulatory role of the C terminus. In contrast, other groups using the corresponding (5, 13) or different (33) rat Ca V 1.3 42 and Ca V 1.3 42A ␣1 subunit analogues found neither major differences in the activation voltage range nor in CDI (13) . Therefore, V 0.5,act and V max values for I Ba as well as the extent of CDI closely resemble our human Ca V 1.3 42A channels (5, 13, 12) . Even though at present the molecular basis for this difference is unclear, chimeric constructs between rat and human Ca V 1.3 constructs expressed under identical experimental conditions (e.g. to exclude confounding effects of the heterologous expression system and/or accessory subunit composition) will help to clarify this question. Our observation of a modulatory C-terminal domain in Ca V 1.3 adds to recent discoveries of a similar regulatory principle in other LTCC isoforms (see Refs. 15, 17, and references therein). Autoinhibitory control of Ca V 1.2 channel function was proposed to be based on a binding interaction between a pair of exposed arginine residues and negatively charged residues in ␣-helical motifs in a proximal (PCRD) and a distal (DCRD) conserved region of the C terminus, respectively (17) . In our human Ca V 1.3 channels, 39 residues (1626 -1664) comprising the proximal conserved domain containing the PCRD were necessary to confer modulation, as well as FRET to coexpressed CTM-containing peptides. Neutralization of the two conserved positive charges in PCRD did not prevent FRET implying other essential motifs within this 39-residue PCRD domain. Evidence for a role of DCRD comes from the finding that two conserved negative charges are required to support binding of CFP-C 116 to the upstream domain.
The functional consequences of LTCC C-terminal modulation appear different in Ca V 1.2 and Ca V 1.3 channels. In Ca V 1.2, C-terminal truncation does not induce a more negative V 0.5,act , but overexpression of the distal C terminus shifts the activation range to more positive voltages and reduces the coupling efficiency of voltage-sensing to channel opening (17) . This is in contrast to Ca V 1.4 and Ca V 1.3 channels in which removal of the CTM facilitates activation within a more negative voltage range and CTM co-expression restores gating (15 and this paper). Differences between LTCCs also exist with respect to the moderation of CDI. Although in both channels the CTM is able to interfere with CaM association, the CTM completely prevents CDI in Ca V 1.4 (15) but only moderates CDI in Ca V 1.3. To our knowledge the effects of the C-terminal autoinhibitory domain on CDI of Ca V 1.2 channels has not been systematically analyzed so far.
Our finding of C-terminal modulation of Ca V 1.3 also raises the important question about potential post-translational proteolytic cleavage in the long C terminus. Such has been reported for Ca V 1.1 and Ca V 1.2 channels (18, 34) . The Ca V 1.2 cleavage product not only serves as a potent autoinhibitor when it remains noncovalently bound to the channel (17) but may also dissociate from the ␣1 subunit thereby serving as a transcriptional regulator after translocation to the nucleus (19) . So far biochemical evidence for Ca V 1.3 C-terminal cleavage is lacking, and it does not appear to function as a transcriptional regulator (19) . Instead, as demonstrated here, alternative splicing can generate short and functionally distinct Ca V 1.3 variants. Such splicing has not yet been reported for Ca V 1.1, Ca V 1.2, or Ca V 1.4 channels.
Our data predict that the expression of Ca V 1.3 42A would allow a cell to promote Ca 2ϩ entry through Ca V 1.3 channels at sub-threshold voltages as predicted from the negative shift of the window current ( Fig. 2e) . Stronger activation at more negative voltages may also facilitate the onset of upstate potentials in neurons. However, during maintained depolarization, the faster CDI would limit Ca 2ϩ entry through these channels as relevant in neurons with Ca V 1.3-dependent pacemaking, e.g. dopamine-containing neurons in the substantia nigra (36) .
Whereas negative activation of an even small Ca V 1.3 current could trigger pacemaking, faster CDI would limit Ca 2ϩ entry during ensuing action potentials. This may be important in these neurons that are susceptible to Ca 2ϩ toxicity and neurodegeneration in Parkinson disease (36) . In contrast, the CTM in Ca V 1.3 42 channels may be required for longer lasting Ca 2ϩ signals triggered by stronger depolarization inducing cAMP-response element-binding protein phosphorylation and synaptic plasticity (37) .
Our study raises several important questions that need to be addressed in future studies. The fact that the increase in current density observed in Ca V 1.3 42A channels seems not to be due to increased expression density (and increased gating currents, see Fig. 2 ) suggests differences in the unitary current (e.g. increase in single-channel conductance or open probability or prolonged open times). Single-channel analysis will also be required to provide a mechanistic explanation for the shift in activation gating parameters in the short Ca V 1.3 channels. Changes in the unitary conductance of Ca V 1.2 channels induced by structural alterations within the CaM interaction domains in the C terminus well outside the known pore-forming regions have been described (38) providing evidence for a conformational link of the CaM binding domain not only with the gating machinery but also with the channel pore.
Several proteins binding to interaction domains of the C terminus have been described. For example, in neurons the multifunctional PDZ protein Erbin binds to a PDZ-binding domain formed by the last four amino acid residues of Ca V 1.3 42 and thereby relieves the autoinhibitory effect of the C terminus on VDF (see Ref. 39 and see above). Also Shank protein (40) and RIM-binding protein (41) are predicted to bind selectively to the C terminus of Ca V 1.3 channels and may therefore affect CTM function. The fact that the distal C terminus comprising the CTM also contains regulatory sites, including sites for cAMP-dependent protein kinase phosphorylation (42) and AKAP-15 (43) , raises the interesting possibility that their interference with the activity of the CTM itself could also serve as mechanism to fine-tune Ca V 1.3 function. Such a mechanism has recently been proposed to explain the still enigmatic mechanism of cAMP-dependent protein kinase-dependent activation of Ca V 1.2 LTCCs (35) .
Taken together, we have identified a modulatory domain in Ca V 1.3 LTCCs responsible for profound differences in the Ca 2ϩ -and voltage-dependent gating of the different C-terminal splice variants. Given that many unique physiological functions of Ca V 1.3 depend on the negative activation range of the channel and the amount of Ca 2ϩ ions entering during plateau (7) or single action potentials (8), our findings identify the CTM and factors that modify its activity (such as alternative splicing) as elements suitable to determine electrical excitability. Future experiments must also address the interesting possibility that interference with this C-terminal regulatory mechanism can also be exploited for pharmacological intervention, as an alternative to classical Ca 2ϩ channel modulators.
